TELA Bio, Inc.

{
  "main_header": {
    "sid": 1237693,
    "name": "TELA Bio, Inc.",
    "stock_name": "TELA Bio, Inc.",
    "full_name": "TELA Bio, Inc.",
    "name_url": "stocks-analysis/tela-bio-inc",
    "exchange": 1,
    "exchangecode": "NAS",
    "country_id": 2,
    "currency": "USD",
    "cmp": "0.80",
    "chg": -1.06,
    "chgp": "-56.99%",
    "dir": -1,
    "prev_price": "1.86",
    "mcapval": "43.42",
    "mcap": "Micro Cap",
    "scripcode": "",
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 2325,
    "indexname": "S&P 500",
    "isin": "US8723811084",
    "curr_date": "Feb 05",
    "curr_time": "",
    "bse_nse_vol": "9.68 M",
    "exc_status": "Active",
    "traded_date": "Feb 05, 2026",
    "traded_date_str": "2026 02 05",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/tela-bio-inc-1237693-1&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "TELA Bio, Inc. Experiences Revision in Its Stock Evaluation Amid Mixed Financial Performance",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/tela-bio-inc-financial-trend-shifts-from-positive-to-very-positive-despite-ongoing-challenges-3718578",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/TELABioInc_fintrenddot_3718578.png",
        "date": "2025-11-20 15:37:30",
        "description": "TELA Bio, Inc. reported flat financial performance for the quarter ending June 2025, with notable achievements in operating cash flow and net sales. However, challenges persist, including low return on capital employed and a declining debtors turnover ratio, amid significant stock declines compared to broader market trends."
      }
    ],
    "total": 6,
    "sid": "1237693",
    "stock_news_url": "https://www.marketsmojo.com/news/tela-bio-inc-1237693"
  },
  "announcements": "",
  "corporate_actions": {
    "msg": "No corporate action Found"
  }
}

News and Views

TELA Bio, Inc. Experiences Revision in Its Stock Evaluation Amid Mixed Financial Performance

2025-11-20 15:37:30

TELA Bio, Inc. reported flat financial performance for the quarter ending June 2025, with notable achievements in operating cash flow and net sales. However, challenges persist, including low return on capital employed and a declining debtors turnover ratio, amid significant stock declines compared to broader market trends.

Read full news article

View All News